Predicting mortality and recurrence in colorectal cancer: Comparative assessment of predictive models
View abstract on PubMed
Summary
This summary is machine-generated.This study evaluated predictive models for colorectal cancer (CRC) mortality and recurrence. The mboost model excelled at predicting mortality, while Gradient Boosting was superior for recurrence prediction in CRC patients.
Area Of Science
- Oncology
- Machine Learning
- Biostatistics
Background
- Colorectal cancer (CRC) is a leading cause of cancer mortality globally.
- Accurate prediction of CRC mortality and recurrence is crucial for patient management.
Purpose Of The Study
- To assess the predictive accuracy of various machine learning models for colorectal cancer mortality.
- To evaluate the performance of these models in predicting disease recurrence in CRC patients.
Main Methods
- Retrospective analysis of 284 CRC patients diagnosed between 2001 and 2017.
- Evaluation of Decision Trees, Random Forests, Random Survival Forests (RSF), Gradient Boosting, mboost, Deep Learning Neural Network (DLNN), and Cox regression models.
- Performance metrics included sensitivity, specificity, positive predictive value (PPV), ROC area, and overall accuracy.
Main Results
- For mortality prediction, mboost achieved the highest accuracy (89%) with 96.9% sensitivity and 0.88 ROC area. Random Forests showed 100% sensitivity but 0% specificity.
- Gradient Boosting demonstrated superior performance for recurrence prediction, with 100% sensitivity, 92.9% specificity, and a 96.4% ROC area.
- DLNN models performed poorly for both mortality and recurrence prediction across all evaluated metrics.
Conclusions
- The mboost model is highly effective for predicting mortality in colorectal cancer patients.
- Gradient Boosting shows excellent potential for predicting recurrence in CRC.
- These findings highlight the utility of specific machine learning models in improving prognostic accuracy for colorectal cancer.
Related Concept Videos
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Survival Times Are Positively Skewed
Survival times often exhibit positive skewness, unlike the normal distribution assumed...

